In a retrospective study involving 36 ccRCC patients, Gao et al. (14) concluded that 68Ga-PSMA-11 PET/CT SUVmax could effectively identify adverse pathology with an AUC of 0.92 (cutoff value=18.5, P<0.001). The gene discussed is FOLH1; the disease is nonpapillary renal cell carcinoma.